This conceptual perspective examines the role of mRNA therapeutics in the context of systems-level dynamics in autoimmune disease. Current treatments for autoimmune disorders largely rely on broad immunosuppression targeting individual molecular pathways. However, autoimmune diseases emerge from complex immune networks involving interacting cell populations, cytokine signaling, and regulatory feedback loops. The article discusses how mRNA-based therapies may enable antigen-specific immune modulation and potentially influence immune network behavior rather than simply blocking single pathways. By linking developments in mRNA technology with systems biology approaches, the paper argues that future therapeutic strategies may require a deeper understanding of dynamic immune system states and network-level regulation.